Cargando…
Target therapy for metastatic alveolar soft part sarcoma: a retrospective study with 47 cases
BACKGROUND: Alveolar soft part sarcoma (ASPS) is a translocation-associated soft-tissue tumor resistant to conventional cytotoxic agents. This report aims to compare the efficacy of anlotinib versus pazopanib as targeted monotherapy in metastatic ASPS and to determine the impact of drug dosage reduc...
Autores principales: | Liu, Jiayong, Fan, Zhengfu, Li, Shu, Gao, Tian, Xue, Ruifeng, Bai, Chujie, Zhang, Lu, Tan, Zhichao, Fang, Zhiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729354/ https://www.ncbi.nlm.nih.gov/pubmed/33313238 http://dx.doi.org/10.21037/atm-20-6377 |
Ejemplares similares
-
Clinical features and therapeutic outcomes of alveolar soft part sarcoma in children: A single-center, retrospective study
por: Tan, Zhichao, et al.
Publicado: (2022) -
Real-world experience with pembrolizumab in patients with advanced soft tissue sarcoma
por: Liu, Jiayong, et al.
Publicado: (2021) -
Phase II Study of TQB2450, a Novel PD-L1 Antibody, in Combination with Anlotinib in Patients with Locally Advanced or Metastatic Soft Tissue Sarcoma
por: Liu, Jiayong, et al.
Publicado: (2022) -
Efficacy of PD-1 inhibitors combined with pegylated liposomal doxorubicin and dacarbazine compared with liposomal doxorubicin and dacarbazine in advanced leiomyosarcoma patients: a retrospective, single-institutional cohort study
por: Tan, Zhichao, et al.
Publicado: (2022) -
KIF18B promotes tumor progression in osteosarcoma by activating β-catenin
por: Gao, Tian, et al.
Publicado: (2020)